• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Nectar Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 23920.0
  • ISIN : INE023H01027
19.88 0 (2.16%)
  • As on 13 Jul 2025 (EOD)

  • Today’s Low

    19.29

  • Today’s High

    20.70

  • Open

    19.56

  • Perv Close

    19.46

  • 52W Low

    15.51

  • 52W High

    56.50

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    445.83

  • Div & Yield %

    0.00

  • Book Value(₹)

    42.63

  • Debt-Equity Ratio

    2.16

  • AGM Date

    11-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.65

  • Mar.Cap (₹Cr.)

    445.83

  • RONW (%)

    0.47

  • ROCE (%)

    5.96

Score Board

  • Equity (₹ in Cr.)

    22.43

  • BV (₹)

    42.60

  • Sales( ₹ in Cr.)

    1,669.97

  • NP (in Cr.)

    -113.68

  • NP Var(%)

    -2458.0

  • Div%

    0.0

  • CPS (₹)

    -2.30

  • EPS (₹)

    -5.10

  • Traded Value (₹ in Lakhs)

    446.95

  • 52 Week High

    56.50

  • 52 Week Low

    15.51

  • Price BSE

    20.0

  • Price NSE

    20.00

  • Market Capital( in Cr.)

    446.95

  • P/C Ratio

    -8.70

  • P/E Ratio

    -3.90

  • Price Vs.BV

    -5.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,925.83 1,746.56 1,924.92 1,762.27 2,639.28 3,114.92
Excise Duty 241.75 222.89 256.69 220.45 276.48 329.99
Net Sales 1,684.08 1,523.67 1,668.23 1,541.82 2,362.80 2,784.93
Other Income 14.58 43.18 11.32 3.79 4.32 6.04
Stock Adjustments 40.21 41.64 -14.97 -102.80 5.25 46.99
Total Income 1,738.87 1,608.49 1,664.58 1,442.81 2,372.37 2,837.96
EXPENDITURE :            
Raw Materials 1,242.45 1,200.84 1,207.32 1,052.82 1,862.83 2,268.13
Power and Fuel Cost 129.52 127.39 101.41 84.63 92.72 103.47
Employee Cost 81.71 75.14 71.91 70.55 78.19 76.54
Other Manufacturing Expenses 55.30 44.88 45.09 44.16 46.39 49.87
Selling and Administration Expenses 61.38 61.01 66.82 72.00 66.18 66.97
Miscellaneous Expenses 2.37 1.32 1.90 31.04 3.72 3.03
Employee Benefit Expenses 81.71 75.14 71.91 70.55 78.19 76.54
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,572.73 1,510.59 1,494.44 1,355.19 2,150.04 2,568.01
Operating Profit 166.13 97.91 170.13 87.63 222.33 269.94
Interest 87.14 79.48 78.81 112.03 125.82 148.13
Gross Profit 78.99 18.43 91.32 -24.40 96.51 121.81
Depreciation 60.72 59.12 56.97 60.25 60.77 63.26
Profit Before Tax 18.27 -40.69 34.35 -84.65 35.74 58.55
Current Tax 13.27 -18.24 9.03 -11.50 1.66 7.41
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 4.02 3.81
Reported Net Profit 5.00 -22.46 25.32 -73.15 30.06 47.33
Extraordinary Items 0.18 40.51 9.41 -25.41 0.22 -0.17
Adjusted Net Profit 4.82 -62.97 15.91 -47.74 29.84 47.50
Adjustment below Net Profit -0.34 0.19 0.81 0.00 1.26 0.03
P & L Balance brought forward 699.27 721.54 695.41 766.26 739.31 693.30
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 1.12 1.35 1.35
P & L Balance carried down 703.93 699.27 721.54 691.99 769.28 739.31
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 5.00 5.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.05 0.05
Earnings Per Share-Unit Curr 0.22 -1.00 1.13 -3.26 1.34 2.11
Earnings Per Share(Adj)-Unit Curr 0.22 -1.00 1.13 -3.26 1.34 2.11
Book Value 47.68 47.47 48.46 47.30 50.59 49.26
Book Value(Adj)-Unit Curr 47.68 47.47 48.46 47.30 50.59 49.26

Shareholding Pattern

  • Promoter Group

    44.53%

  • Public Share Holding

    55.47%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 99,868,000 44.53 99,868,000 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 99,868,000 44.53 99,868,000 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 44,020 0.02 44,020 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,690,831 1.65 3,690,831 22
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 350,000 0.16 350,000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,084,851 1.82 4,084,851 25
2] Non Institution
Bodies Corporate 15,632,277 6.97 15,632,267 320
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,937,855 1.31 2,937,855 640
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 8,304,245 3.70 8,304,245 1,457
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 26,013,910 11.60 26,013,910 35
Individuals holding nominal share capital up to Rs. 1 lakh 67,283,719 30.00 67,282,359 66,758
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 135,613 0.06 135,613 2
Sub Total 120,308,119 53.65 120,306,749 69,213
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 224,260,970 100.00 224,259,600 69,241

Company Background

Nectar Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Nectar Lifescience Ltd
  • BSE Code : 23920.0
  • ISIN : INE023H01027

  • Incorporation Year

    1995

  • Registered Office

    Village Saidpura
    Tehsil Derabassi S A S Nagar, Mohali,
    Punjab-140507

  • Telephone

    91-1762-308000

  • FAX

    91-1762-308135

  • Chairman

    Sanjiv Goyal

  • Managing Director

    Sanjiv Goyal

  • Company Secretary

  • Auditor

    Deepak Jindal & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Nectar Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Nectar Lifesci. 19.93 1,698.66 1,925.83 -3.93 5.96
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10